113 related articles for article (PubMed ID: 37946519)
41. MiR-214 Regulates the Human Hair Follicle Stem Cell Proliferation and Differentiation by Targeting EZH2 and Wnt/β-Catenin Signaling Way
Du KT; Deng JQ; He XG; Liu ZP; Peng C; Zhang MS
Tissue Eng Regen Med; 2018 Jun; 15(3):341-350. PubMed ID: 30603559
[TBL] [Abstract][Full Text] [Related]
42. TCF4/β-catenin complex is directly upstream of
Pei J; Song N; Wu L; Qi J; Xia S; Xu C; Zheng B; Yang J; Qiu Y; Wang H; Jiang Y
Exp Ther Med; 2018 Jan; 15(1):1041-1047. PubMed ID: 29434695
[TBL] [Abstract][Full Text] [Related]
43. β-catenin/TCF4 inhibitors ICG-001 and LF3 alleviate BDL-induced liver fibrosis by suppressing LECT2 signaling.
Gao Y; Fan S; Zhao P; Li H; Cai C; Li X; Zhou Y; Huang M; Bi H
Chem Biol Interact; 2023 Feb; 371():110350. PubMed ID: 36639009
[TBL] [Abstract][Full Text] [Related]
44. MiR-522-3p inhibits proliferation and activation by regulating the expression of SLC31A1 in T cells.
Lu H; Wang H; Sun P; Wang J; Li S; Xu T
Cytotechnology; 2021 Jun; 73(3):483-496. PubMed ID: 34149179
[TBL] [Abstract][Full Text] [Related]
45. MiR-93 inhibits the vascular calcification of chronic renal failure by suppression of Wnt/β-catenin pathway.
Peng J; Qin C; Tian SY; Peng JQ
Int Urol Nephrol; 2022 Jan; 54(1):225-235. PubMed ID: 34138419
[TBL] [Abstract][Full Text] [Related]
46. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
[TBL] [Abstract][Full Text] [Related]
47. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
[TBL] [Abstract][Full Text] [Related]
48. TCF4 Is a Molecular Target of Resveratrol in the Prevention of Colorectal Cancer.
Jeong JB; Lee J; Lee SH
Int J Mol Sci; 2015 May; 16(5):10411-25. PubMed ID: 25961950
[TBL] [Abstract][Full Text] [Related]
49. Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.
Yamada H; Furuuchi K; Aoyama T; Kataoka A; Hamada J; Tada M; Okushiba S; Kondo S; Moriuchi T; Katoh H
Am J Pathol; 2003 Dec; 163(6):2201-9. PubMed ID: 14633595
[TBL] [Abstract][Full Text] [Related]
50. miR-129-5p Inhibits Bone Formation Through TCF4.
Yin C; Tian Y; Yu Y; Yang C; Su P; Zhao Y; Wang X; Zhang K; Pei J; Li D; Chen Z; Zhang Y; Miao Z; Qian A
Front Cell Dev Biol; 2020; 8():600641. PubMed ID: 33240893
[TBL] [Abstract][Full Text] [Related]
51. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
[TBL] [Abstract][Full Text] [Related]
52. MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.
Yu FB; Sheng J; Yu JM; Liu JH; Qin XX; Mou B
World J Gastroenterol; 2020 Feb; 26(6):627-644. PubMed ID: 32103872
[TBL] [Abstract][Full Text] [Related]
53. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
54. [Optimizations of an ELISA-like high-throughput screening assay for the discovery of β-catenin/TCF4 interaction antagonists].
Fu Z; Yan G; Zhu X; Liu X; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2021 Aug; 37(8):2878-2889. PubMed ID: 34472305
[TBL] [Abstract][Full Text] [Related]
55. Activation of Wnt/β-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression.
Wang N; Huo R; Cai B; Lu Y; Ye B; Li X; Li F; Xu H
Free Radic Biol Med; 2016 Jul; 96():34-44. PubMed ID: 27068063
[TBL] [Abstract][Full Text] [Related]
56. Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy.
Fujita K; Motoyama S; Sato Y; Wakita A; Nagaki Y; Minamiya Y; Miura M
Med Oncol; 2021 Jan; 38(1):6. PubMed ID: 33411033
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
[TBL] [Abstract][Full Text] [Related]
58. Daxx positively modulates beta-catenin/TCF4-mediated transcriptional potential.
Huang YS; Shih HM
Biochem Biophys Res Commun; 2009 Sep; 386(4):762-8. PubMed ID: 19563778
[TBL] [Abstract][Full Text] [Related]
59. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
[TBL] [Abstract][Full Text] [Related]
60. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
